TCL Archive Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials July 11, 2003
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments January 8, 1982